Nov 06, 2018
Biostage awarded $1.1 million Phase II NIH SBIR Fast-Track grant to develop Cellspan(TM) Esophageal Implant (CEI) as a novel treatment for pediatric esophageal atresia
Nov 02, 2018
Biostage to Host Conference Call to Discuss Third Quarter 2018 Financial Results and Operations
Aug 14, 2018
Biostage Reports 2018 Second Quarter Financial Results
Aug 09, 2018
Biostage to Host Conference Call to Discuss Second Quarter 2018 Financial Results and Operations
May 31, 2018
Biostage Closes $3.6 Million Private Placement at a price of $3.60 per share
May 31, 2018
Hong Yu Appointed President of Biostage
May 25, 2018
Dr. Wei Zhang Elected to Biostage's Board of Directors
May 10, 2018
Biostage Reports 2018 First Quarter Financial Results
May 04, 2018
Biostage to Host Conference Call to Discuss First Quarter 2018 Financial Results and Operations
Apr 02, 2018
Biostage Reports 2017 Financial Results
Mar 29, 2018
Biostage awarded SBIR Fast-Track grant to develop Cellspan(TM) Esophageal Implant (CEI) as a novel treatment for esophageal atresia in pediatric patients
Mar 13, 2018
Biostage Preclinical Study Results Published in New Report
Feb 20, 2018
Biostage Closes $1 Million Private Placement
Jan 31, 2018
Biostage Appoints to its Scientific Advisory Board Christine Finck, MD, Executive Vice President, Surgeon-in-Chief at Connecticut Children's Medical Center
Dec 22, 2017
Biostage Announces Reverse Stock Split Effective December 22, 2017
Oct 12, 2017
Biostage Conducts Reduction In Force, Evaluating Strategic Alternatives
Oct 06, 2017
Biostage to Move to OTCQB Marketplace